350 related articles for article (PubMed ID: 22747486)
1. Sphingosine kinase type 2 inhibition elevates circulating sphingosine 1-phosphate.
Kharel Y; Raje M; Gao M; Gellett AM; Tomsig JL; Lynch KR; Santos WL
Biochem J; 2012 Oct; 447(1):149-57. PubMed ID: 22747486
[TBL] [Abstract][Full Text] [Related]
2. Sphingosine kinase type 1 inhibition reveals rapid turnover of circulating sphingosine 1-phosphate.
Kharel Y; Mathews TP; Gellett AM; Tomsig JL; Kennedy PC; Moyer ML; Macdonald TL; Lynch KR
Biochem J; 2011 Dec; 440(3):345-53. PubMed ID: 21848514
[TBL] [Abstract][Full Text] [Related]
3. The sphingosine kinase 1 and S1P1 axis specifically counteracts LPS-induced IL-12p70 production in immune cells of the spleen.
Schröder M; Richter C; Juan MH; Maltusch K; Giegold O; Quintini G; Pfeilschifter JM; Huwiler A; Radeke HH
Mol Immunol; 2011 May; 48(9-10):1139-48. PubMed ID: 21435724
[TBL] [Abstract][Full Text] [Related]
4. Sphingosine Kinase 2 Inhibition and Blood Sphingosine 1-Phosphate Levels.
Kharel Y; Morris EA; Congdon MD; Thorpe SB; Tomsig JL; Santos WL; Lynch KR
J Pharmacol Exp Ther; 2015 Oct; 355(1):23-31. PubMed ID: 26243740
[TBL] [Abstract][Full Text] [Related]
5. Sphingosine 1-Phosphate Produced by Sphingosine Kinase 2 Intrinsically Controls Platelet Aggregation In Vitro and In Vivo.
Urtz N; Gaertner F; von Bruehl ML; Chandraratne S; Rahimi F; Zhang L; Orban M; Barocke V; Beil J; Schubert I; Lorenz M; Legate KR; Huwiler A; Pfeilschifter JM; Beerli C; Ledieu D; Persohn E; Billich A; Baumruker T; Mederos y Schnitzler M; Massberg S
Circ Res; 2015 Jul; 117(4):376-87. PubMed ID: 26129975
[TBL] [Abstract][Full Text] [Related]
6. Modulation of cellular S1P levels with a novel, potent and specific inhibitor of sphingosine kinase-1.
Schnute ME; McReynolds MD; Kasten T; Yates M; Jerome G; Rains JW; Hall T; Chrencik J; Kraus M; Cronin CN; Saabye M; Highkin MK; Broadus R; Ogawa S; Cukyne K; Zawadzke LE; Peterkin V; Iyanar K; Scholten JA; Wendling J; Fujiwara H; Nemirovskiy O; Wittwer AJ; Nagiec MM
Biochem J; 2012 May; 444(1):79-88. PubMed ID: 22397330
[TBL] [Abstract][Full Text] [Related]
7. Extracellular export of sphingosine kinase-1a contributes to the vascular S1P gradient.
Venkataraman K; Thangada S; Michaud J; Oo ML; Ai Y; Lee YM; Wu M; Parikh NS; Khan F; Proia RL; Hla T
Biochem J; 2006 Aug; 397(3):461-71. PubMed ID: 16623665
[TBL] [Abstract][Full Text] [Related]
8. Mice deficient in sphingosine kinase 1 are rendered lymphopenic by FTY720.
Allende ML; Sasaki T; Kawai H; Olivera A; Mi Y; van Echten-Deckert G; Hajdu R; Rosenbach M; Keohane CA; Mandala S; Spiegel S; Proia RL
J Biol Chem; 2004 Dec; 279(50):52487-92. PubMed ID: 15459201
[TBL] [Abstract][Full Text] [Related]
9. Sphingosine kinase inhibitors: a review of patent literature (2006-2015).
Lynch KR; Thorpe SB; Santos WL
Expert Opin Ther Pat; 2016 Dec; 26(12):1409-1416. PubMed ID: 27539678
[TBL] [Abstract][Full Text] [Related]
10. Design of Sphingosine Kinases Inhibitors: Challenges and Recent Developments.
Magli E; Corvino A; Fiorino F; Frecentese F; Perissutti E; Saccone I; Santagada V; Caliendo G; Severino B
Curr Pharm Des; 2019; 25(9):956-968. PubMed ID: 30947653
[TBL] [Abstract][Full Text] [Related]
11. Different Roles of Sphingosine Kinase 1 and 2 in Pancreatic Cancer Progression.
Yuza K; Nakajima M; Nagahashi M; Tsuchida J; Hirose Y; Miura K; Tajima Y; Abe M; Sakimura K; Takabe K; Wakai T
J Surg Res; 2018 Dec; 232():186-194. PubMed ID: 30463717
[TBL] [Abstract][Full Text] [Related]
12. Differential regulation of sphingosine kinases 1 and 2 in lung injury.
Wadgaonkar R; Patel V; Grinkina N; Romano C; Liu J; Zhao Y; Sammani S; Garcia JG; Natarajan V
Am J Physiol Lung Cell Mol Physiol; 2009 Apr; 296(4):L603-13. PubMed ID: 19168577
[TBL] [Abstract][Full Text] [Related]
13. Structure-activity relationship studies and in vivo activity of guanidine-based sphingosine kinase inhibitors: discovery of SphK1- and SphK2-selective inhibitors.
Patwardhan NN; Morris EA; Kharel Y; Raje MR; Gao M; Tomsig JL; Lynch KR; Santos WL
J Med Chem; 2015 Feb; 58(4):1879-1899. PubMed ID: 25643074
[TBL] [Abstract][Full Text] [Related]
14. Rational design of SphK inhibitors using crystal structures aided by computer.
Ding T; Zhi Y; Xie W; Yao Q; Liu B
Eur J Med Chem; 2021 Mar; 213():113164. PubMed ID: 33454547
[TBL] [Abstract][Full Text] [Related]
15. Building a better sphingosine kinase-1 inhibitor.
Lynch KR
Biochem J; 2012 May; 444(1):e1-2. PubMed ID: 22533672
[TBL] [Abstract][Full Text] [Related]
16. The sphingosine kinase 1/sphingosine-1-phosphate pathway in pulmonary arterial hypertension.
Chen J; Tang H; Sysol JR; Moreno-Vinasco L; Shioura KM; Chen T; Gorshkova I; Wang L; Huang LS; Usatyuk PV; Sammani S; Zhou G; Raj JU; Garcia JG; Berdyshev E; Yuan JX; Natarajan V; Machado RF
Am J Respir Crit Care Med; 2014 Nov; 190(9):1032-43. PubMed ID: 25180446
[TBL] [Abstract][Full Text] [Related]
17. Vascular endothelium as a contributor of plasma sphingosine 1-phosphate.
Venkataraman K; Lee YM; Michaud J; Thangada S; Ai Y; Bonkovsky HL; Parikh NS; Habrukowich C; Hla T
Circ Res; 2008 Mar; 102(6):669-76. PubMed ID: 18258856
[TBL] [Abstract][Full Text] [Related]
18. Deletion of the sphingosine kinase-1 gene influences cell fate during hypoxia and glucose deprivation in adult mouse cardiomyocytes.
Tao R; Zhang J; Vessey DA; Honbo N; Karliner JS
Cardiovasc Res; 2007 Apr; 74(1):56-63. PubMed ID: 17320845
[TBL] [Abstract][Full Text] [Related]
19. Transforming Sphingosine Kinase 1 Inhibitors into Dual and Sphingosine Kinase 2 Selective Inhibitors: Design, Synthesis, and in Vivo Activity.
Childress ES; Kharel Y; Brown AM; Bevan DR; Lynch KR; Santos WL
J Med Chem; 2017 May; 60(9):3933-3957. PubMed ID: 28406646
[TBL] [Abstract][Full Text] [Related]
20. Drugging sphingosine kinases.
Santos WL; Lynch KR
ACS Chem Biol; 2015 Jan; 10(1):225-33. PubMed ID: 25384187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]